USFDA Guidance on Providing Regulatory Submissions in Alternate Electronic Format
SFDA's Guidance on Data Requirements for the Renewal of Marketing Authorizations Drug Products
India MoH's - Draft Proposal for adding QR Codes for important SCHEDULE H2 Drugs
South Africa SAPHRA - Post-marketing Reporting of Adverse Drug Reaction
Philippines FDA - Guidelines on Abridged and Verification Review Pathways for New Drug Registration
Ireland's HPRA -Guide to Performance Studies Conducted in Ireland
USFDA Guidance on Technical Performance Assessment of Quantitative Imaging in Radiological Device
ICH - Q9(R1) Quality Risk Management Draft Guidance Uupdation
USFDA Guidance - Assessment of the UI of a Drug-Device Combination - Pre-ANDA or ANDA Communication
Malaysia’s - DRAFT GUIDANCE DOCUMENT LICENSING FOR ESTABLISHMENT
Guidance documents for Therapeutic Products
Swissmedic - Guidance on known Active Pharmaceutical Substance & Time limits for Authorisation
USFDA's Guidance of Electromagnetic Compatibility (EMC) of Medical Devices
EMA- New Guidance on Complex Clinical Trials